Peptic Ulcer Disease & Stomach Ulcer Treatment in Dallas, TX

What Is Peptic Ulcer Disease?

Peptic ulcer disease (PUD) refers to open sores — called ulcers — that develop on the inner lining of the stomach (gastric ulcers), the upper portion of the small intestine known as the duodenum (duodenal ulcers), or, less commonly, the lower esophagus. These ulcers form when the protective mucus layer that shields the stomach and duodenal lining from digestive acid is damaged or diminished, allowing hydrochloric acid and the digestive enzyme pepsin to erode the underlying tissue.

Peptic ulcer disease remains a common gastrointestinal condition. According to the American College of Gastroenterology (ACG), approximately 6% of the U.S. population has peptic ulcer disease, with an estimated 500,000 new cases diagnosed annually. While the overall prevalence of peptic ulcer disease has declined significantly since the discovery of Helicobacter pylori (H. pylori) and the advent of effective eradication therapy, the condition continues to be a major cause of morbidity. Ulcer complications — particularly gastrointestinal bleeding — still account for approximately 150,000 hospitalizations and several thousand deaths each year in the United States.

At Texas Gut Health in Sachse, TX, Dr. Jaison John provides thorough evaluation and evidence-based treatment for peptic ulcer disease, including H. pylori testing and eradication, upper endoscopy (EGD) for diagnosis and treatment of bleeding ulcers, and long-term management strategies to prevent recurrence. Dr. John completed his gastroenterology fellowship at UT Medical Branch, where he served as Chief Fellow, and his internal medicine residency at UT Austin Dell Medical School, where he served as Chief Resident. He holds dual board certifications from the American Board of Internal Medicine in both internal medicine and gastroenterology.

Types of Peptic Ulcers

Peptic ulcers are classified based on their anatomic location, and each type has somewhat different clinical characteristics and implications for management.

Gastric Ulcers

Gastric ulcers occur in the stomach, most commonly along the lesser curvature. Pain from gastric ulcers typically worsens within 30 minutes of eating, which can lead to food avoidance and weight loss. All gastric ulcers discovered during endoscopy should be biopsied to exclude malignancy (gastric cancer) and should be followed with a repeat endoscopy after 8 to 12 weeks of PPI therapy to confirm healing. Non-healing gastric ulcers require further investigation.

Duodenal Ulcers

Duodenal ulcers are the more common type, occurring in the duodenal bulb (the first portion of the small intestine immediately beyond the stomach). Duodenal ulcer pain classically occurs 2 to 3 hours after eating and is relieved by food or antacids, as food buffers the acid. Patients may experience pain that awakens them at night. Duodenal ulcers are almost never malignant and are more strongly associated with H. pylori infection than gastric ulcers.

Symptoms of Peptic Ulcer Disease

The symptoms of peptic ulcer disease can range from mild, intermittent discomfort to severe, acute pain signaling a complication. Many ulcers are initially asymptomatic and are discovered only when a complication such as bleeding occurs.

Common Symptoms

• Burning or gnawing epigastric pain — The classic symptom of peptic ulcer disease is a burning, aching, or gnawing pain in the upper abdomen, located between the navel and the breastbone. The pain is often described as "hunger-like" and may come and go over days to weeks.
• Pain pattern related to meals — Duodenal ulcer pain typically occurs on an empty stomach (2 to 5 hours after eating) and is relieved by eating or taking antacids. Gastric ulcer pain tends to occur shortly after eating and may be worsened by food.
• Nighttime pain — Many patients with duodenal ulcers experience pain that awakens them between midnight and 3 AM, when gastric acid secretion peaks and the stomach is empty.
• Bloating and fullness — A sensation of abdominal bloating, early satiety (feeling full after eating only a small amount), and upper abdominal distention are common.
• Nausea — Nausea, with or without vomiting, can accompany peptic ulcer disease, particularly with gastric ulcers.
• Loss of appetite and weight loss — Some patients, especially those with gastric ulcers, avoid eating because of pain-related food aversion, leading to reduced caloric intake and weight loss.

Alarm Symptoms (Signs of Complications)

• Hematemesis (vomiting blood) — Vomiting bright red blood or material that looks like coffee grounds indicates an actively bleeding or recently bleeding ulcer and requires urgent medical evaluation.
• Melena (black, tarry stools) — Dark, tarry, foul-smelling stools indicate upper gastrointestinal bleeding, as digested blood turns stool black.
• Sudden, severe abdominal pain — Acute, intense, "board-like" abdominal pain may indicate ulcer perforation — a surgical emergency in which the ulcer has eroded through the full thickness of the stomach or duodenal wall.
• Persistent vomiting — Recurrent vomiting of undigested food may indicate gastric outlet obstruction caused by ulcer-related swelling or scarring at the pylorus.
• Unexplained weight loss or anemia — Chronic, occult (hidden) blood loss from an ulcer can cause iron deficiency anemia, presenting as fatigue, pallor, and shortness of breath on exertion.

Causes & Risk Factors

The understanding of peptic ulcer disease was transformed by the 1982 discovery that H. pylori infection — not stress or spicy food — is a primary cause of most ulcers. Today, the two dominant causes of peptic ulcer disease are H. pylori infection and NSAID use.

Helicobacter pylori Infection

H. pylori is a spiral-shaped bacterium that colonizes the gastric mucosa (stomach lining) and is one of the most common chronic bacterial infections worldwide, affecting approximately 35% to 40% of the U.S. population. H. pylori damages the stomach's protective mucus layer through several mechanisms: it produces urease (which generates ammonia to neutralize local acid and damage epithelial cells), triggers a chronic inflammatory response, and disrupts the normal balance between acid secretion and mucosal defense. H. pylori is present in approximately 60% to 70% of patients with gastric ulcers and 70% to 90% of patients with duodenal ulcers. Eradication of H. pylori dramatically reduces ulcer recurrence from approximately 60% to 80% per year down to less than 5%.

NSAID Use

Nonsteroidal anti-inflammatory drugs (NSAIDs) are the second most common cause of peptic ulcers. Common NSAIDs include ibuprofen (Advil, Motrin), naproxen (Aleve), diclofenac, and aspirin. NSAIDs cause ulcers by inhibiting the enzyme cyclooxygenase (COX), which reduces the production of prostaglandins — chemical messengers that are essential for maintaining the protective mucus lining of the stomach and duodenum, promoting mucosal blood flow, and stimulating bicarbonate secretion. Without adequate prostaglandin protection, the gastric and duodenal mucosa become vulnerable to acid-mediated damage. The risk of NSAID-related ulcers and complications increases with higher doses, longer duration of use, older age, concomitant use of corticosteroids or anticoagulants, and a personal history of peptic ulcer disease.

Other Causes and Risk Factors

• Smoking — Cigarette smoking increases the risk of developing peptic ulcers, impairs ulcer healing, and increases the risk of ulcer recurrence and complications. Smoking reduces mucosal blood flow, inhibits prostaglandin synthesis, and may enhance H. pylori virulence.
• Heavy alcohol use — While alcohol alone does not typically cause peptic ulcers, heavy alcohol consumption can irritate and erode the gastric mucosa, increase acid secretion, and compound the damaging effects of NSAIDs and H. pylori.
• Zollinger-Ellison syndrome — This rare condition involves tumors (gastrinomas) that produce excessive amounts of the hormone gastrin, leading to extreme gastric acid hypersecretion and severe, refractory peptic ulcers, often in unusual locations (such as the jejunum).
• Physiologic stress — Critically ill patients (those in intensive care with mechanical ventilation, severe burns, head injuries, or multiorgan failure) can develop stress ulcers due to impaired mucosal blood flow and defense mechanisms.
• Older age — The risk of peptic ulcer disease and its complications increases with age, in part because of higher rates of NSAID use, H. pylori infection, and reduced mucosal defense in older adults.

How Peptic Ulcer Disease Is Diagnosed

The diagnosis of peptic ulcer disease involves a combination of clinical assessment, testing for H. pylori, and, when indicated, direct visualization of the ulcer through upper endoscopy.

Upper Endoscopy (EGD)

Upper endoscopy is the gold standard for diagnosing peptic ulcer disease. During this procedure, Dr. John passes a thin, flexible endoscope through the mouth and into the esophagus, stomach, and duodenum to directly visualize the mucosal surface. Endoscopy allows identification of ulcers (including their size, depth, and location), assessment for active bleeding or other complications, and collection of tissue biopsies. Biopsies are routinely taken from gastric ulcers to rule out malignancy and to test for H. pylori infection (using rapid urease testing and histologic evaluation). The ACG recommends EGD for patients with alarm symptoms, those over 60 with new-onset dyspepsia, patients who fail empiric therapy, and for follow-up of gastric ulcers to confirm healing.

Testing for H. pylori

Because H. pylori infection is a primary cause of peptic ulcers, testing for the bacteria is an essential part of the diagnostic workup. Available tests include:

• Urea breath test — A non-invasive test in which the patient swallows a small amount of urea labeled with a carbon isotope. If H. pylori is present, it produces urease that breaks down the urea, releasing labeled carbon dioxide that can be detected in the breath. This test has excellent sensitivity (greater than 95%) and specificity.
• Stool antigen test — A non-invasive test that detects H. pylori antigens in a stool sample. It has comparable accuracy to the breath test and is particularly useful for confirming eradication after treatment.
• Endoscopic biopsy — Tissue samples taken during EGD can be tested for H. pylori using rapid urease testing (CLO test), histologic staining, and, when needed, culture and antibiotic sensitivity testing.
• Blood antibody test — Serologic testing detects antibodies against H. pylori but cannot distinguish between active and past infection. It is generally not recommended for diagnosis in areas where H. pylori prevalence is below 60% and is not useful for confirming eradication.

Important: Proton pump inhibitors (PPIs), bismuth preparations, and antibiotics should be discontinued for at least 2 weeks (PPIs) or 4 weeks (antibiotics and bismuth) before non-invasive H. pylori testing to avoid false-negative results.

Laboratory Tests

Blood tests may include a complete blood count (to check for anemia from chronic blood loss), serum iron studies, and a basic metabolic panel. Fasting gastrin levels may be measured if Zollinger-Ellison syndrome is suspected (particularly in patients with multiple, refractory, or atypically located ulcers).

Treatment Options

The treatment of peptic ulcer disease focuses on three goals: healing the ulcer, eliminating the underlying cause, and preventing recurrence and complications. Modern treatment is highly effective, with ulcer healing rates exceeding 90% when the appropriate therapy is used.

Acid Suppression with Proton Pump Inhibitors

Proton pump inhibitors (PPIs) are the cornerstone of peptic ulcer treatment. By potently inhibiting gastric acid production, PPIs create an environment that allows the ulcerated mucosa to heal. Standard PPI regimens for ulcer healing include once-daily dosing for 4 weeks (for uncomplicated duodenal ulcers) or 8 to 12 weeks (for gastric ulcers and complicated ulcers). Commonly used PPIs include omeprazole, esomeprazole, lansoprazole, and pantoprazole. PPIs should be taken 30 to 60 minutes before the first meal of the day for optimal efficacy.

H. pylori Eradication Therapy

When H. pylori infection is identified, eradication therapy is essential and is the single most important step in preventing ulcer recurrence. The ACG recommends the following first-line regimens, based on prior macrolide exposure and local clarithromycin resistance rates:

• Bismuth quadruple therapy — A PPI, bismuth subsalicylate, metronidazole, and tetracycline for 14 days. This is the preferred first-line regimen when clarithromycin resistance is suspected or when the patient has prior macrolide exposure.
• Clarithromycin triple therapy — A PPI, clarithromycin, and amoxicillin (or metronidazole) for 14 days. This regimen is appropriate only in regions where clarithromycin resistance is below 15% and in patients without prior macrolide exposure.
• Concomitant therapy — A PPI, clarithromycin, amoxicillin, and metronidazole (all four given simultaneously) for 14 days.

Confirmation of H. pylori eradication is recommended at least 4 weeks after completing antibiotic therapy, using a urea breath test or stool antigen test. Eradication failure requires a different antibiotic combination (avoiding previously used antibiotics) and, ideally, culture-guided therapy based on antibiotic sensitivity testing.

Managing NSAID-Related Ulcers

For NSAID-related peptic ulcers, the most important step is discontinuing the offending NSAID whenever possible, combined with PPI therapy to heal the ulcer. If NSAID use must continue for medical reasons, strategies to reduce ulcer risk include using the lowest effective NSAID dose for the shortest possible duration, co-prescribing a PPI for gastroprotection, considering a COX-2 selective inhibitor (celecoxib) instead of a traditional NSAID, and testing for and treating H. pylori (as the combination of H. pylori infection and NSAID use synergistically increases ulcer risk).

Endoscopic Treatment for Bleeding Ulcers

For patients presenting with upper gastrointestinal bleeding from a peptic ulcer, urgent upper endoscopy is performed within 24 hours to identify the bleeding source and apply endoscopic hemostasis. Techniques include injection of epinephrine, thermal coagulation (bipolar electrocautery or heater probe), and mechanical hemostasis (hemoclips). The ACG recommends combination therapy (injection plus thermal or mechanical) for actively bleeding ulcers and visible vessels. After successful endoscopic hemostasis, high-dose intravenous PPI therapy is administered to prevent rebleeding.

Lifestyle Modifications

While lifestyle changes alone do not heal peptic ulcers, they support the healing process and reduce recurrence risk:

• Stop smoking — smoking impairs ulcer healing and increases recurrence.
• Limit or avoid alcohol — alcohol irritates the gastric mucosa.
• Avoid NSAIDs — use acetaminophen for pain when possible.
• Eat regular meals — do not skip meals, as prolonged fasting increases gastric acid exposure.
• Manage stress — while stress does not directly cause ulcers, it can exacerbate symptoms and impair healing.

Follow-Up and Monitoring

Follow-up care is an essential component of peptic ulcer management. Gastric ulcers should be reassessed with a repeat endoscopy after 8 to 12 weeks of PPI therapy to confirm healing and to rebiopsy any non-healed areas to exclude malignancy. Confirmation of H. pylori eradication should be performed at least 4 weeks after completing antibiotic therapy. Patients requiring ongoing NSAID therapy should be monitored regularly and maintained on gastroprotective PPI therapy.

Living With Peptic Ulcer Disease

With modern medical treatment, the outlook for patients with peptic ulcer disease is excellent. The vast majority of ulcers heal completely within 4 to 8 weeks of appropriate therapy, and successful H. pylori eradication reduces the annual ulcer recurrence rate from approximately 60% to 80% down to less than 5%. Understanding your condition, adhering to your treatment plan, and making sustainable lifestyle adjustments are the keys to long-term success.

Patients who have experienced a peptic ulcer should be especially cautious about NSAID use going forward. Even occasional use of over-the-counter ibuprofen, naproxen, or aspirin can trigger a recurrence or complication. Many common cold, headache, and menstrual pain medications contain NSAIDs, so it is important to read labels carefully and use acetaminophen as an alternative when appropriate. If you require ongoing NSAID therapy for a medical condition such as arthritis, discuss gastroprotective strategies with your gastroenterologist.

Smoking cessation is one of the most impactful lifestyle changes for patients with a history of peptic ulcer disease. Smoking delays ulcer healing, increases the risk of recurrence, and amplifies the risk of complications. If you smoke, your care team at Texas Gut Health can connect you with smoking cessation resources and support. Moderating alcohol intake, eating regular balanced meals, and managing stress through healthy coping strategies also contribute to digestive wellness and help prevent symptom flares.

Regular follow-up with your gastroenterologist is important, particularly in the first year after diagnosis. Dr. John and the team at Texas Gut Health provide comprehensive ongoing care for patients with peptic ulcer disease throughout Sachse, Murphy, Wylie, Plano, Garland, Rowlett, Richardson, and the greater Dallas-Fort Worth area. Contact us at (214) 624-6596 to schedule your follow-up appointment.

Frequently Asked Questions